Literature DB >> 18840622

High-sensitivity C-reactive protein is not independently associated with peripheral subclinical atherosclerosis.

Mario Bo1, Laura Corsinovi, Alessia Brescianini, Alessandro Sona, Marco Astengo, Raluca Dumitrache, Maria Federica Ferrio, Larisa Pricop, Gianfranco Fonte.   

Abstract

OBJECTIVE: This study investigated whether high-sensitivity C-reactive protein (hs-CRP) levels are independently associated with subclinical peripheral atherosclerosis.
METHODS: Clinical variables, cardiovascular (CV) risk factors, 10-year CV risk, the ankle-brachial Index (ABI), and the carotid intima-media thickness (cIMT) were determined in a sample of consecutive subjects free from previous CV disease, admitted for a first visit at a lipid clinic.
RESULTS: In the overall sample (320 subjects, mean age 63 years, 35.8% men), hs-CRP levels were associated with major CV risk factors, 10-year CV risk, lower ABI, and higher cIMT values. In a logistic model, after adjustment for significant covariates, the associations of hs-CRP levels with ABI and cIMT were no longer statistically significant.
CONCLUSIONS: Among asymptomatic, moderate- to-high CV risk subjects, hs-CRP levels were associated with severity of peripheral atherosclerosis, but these associations were not independent of traditional CV risk factors, suggesting a limited predictive role of hs-CRP for subclinical atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840622     DOI: 10.1177/0003319708322387

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population.

Authors:  K Syvänen; P Korhonen; P Jaatinen; T Vahlberg; P Aarnio
Journal:  Int J Angiol       Date:  2011-03

2.  High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk.

Authors:  Jing Li; Andreas J Flammer; Martin K Reriani; Yoshiki Matsuo; Rajiv Gulati; Paul A Friedman; Randal J Thomas; Nicole P Sandhu; Lilach O Lerman; Amir Lerman
Journal:  Circ J       Date:  2012-12-06       Impact factor: 2.993

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.